setmelanotide
Showing 1 - 13 of 13
Hypothalamic Obesity Trial in Gainesville (Setmelanotide, Placebo)
Recruiting
- Hypothalamic Obesity
- Setmelanotide
- Placebo
-
Gainesville, FloridaUniversity of Florida
Mar 16, 2023
Hypothalamic Obesity Trial in United States (Setmelanotide)
Completed
- Hypothalamic Obesity
- Setmelanotide
-
San Diego, California
- +4 more
Dec 15, 2022
Healthy Trial in Glendale (Setmelanotide, Moxifloxacin, Oral Placebo)
Completed
- Healthy
- Setmelanotide
- +3 more
-
Glendale, CaliforniaParexel Early Phase Clinical Unit (Los Angeles)
Jun 15, 2022
Hypertriglyceridemia, Obesity Trial in Ann Arbor (Setmelanotide)
Completed
- Hypertriglyceridemia
- Obesity
- Setmelanotide
-
Ann Arbor, MichiganUniversity of Michigan
Dec 13, 2021
Bardet-Biedl Syndrome, POMC Deficiency Obesity, PCSK1 Deficiency Obesity Trial in Worldwide (Setmelanotide)
Active, not recruiting
- Bardet-Biedl Syndrome
- +3 more
- Setmelanotide
-
Aurora, Colorado
- +5 more
Jul 21, 2022
Obesity Associated With Defects in Leptin-melanocortin Pathway Trial in Worldwide (Setmelanotide)
Enrolling by invitation
- Obesity Associated With Defects in Leptin-melanocortin Pathway
- Setmelanotide
-
Chandler, Arizona
- +31 more
Dec 6, 2022
Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway Trial (Setmelanotide, Placebo)
Not yet recruiting
- Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway
- Setmelanotide
- Placebo
- (no location specified)
Oct 13, 2021
Genetic Obesity Trial in Spain, United Kingdom, United States (Setmelanotide, Placebo)
Recruiting
- Genetic Obesity
- Setmelanotide
- Placebo
-
Dearborn, Michigan
- +13 more
Jun 14, 2022
Renal Insufficiency Trial in United States (Setmelanotide)
Completed
- Renal Insufficiency
- Setmelanotide
-
Miami, Florida
- +3 more
Jun 28, 2021
Bardet Biedl Syndrome (BBS), Alström Syndrome (AS) Trial in Worldwide (Setmelanotide, Placebos)
Completed
- Bardet Biedl Syndrome (BBS)
- Alström Syndrome (AS)
- Setmelanotide
- Placebos
-
San Diego, California
- +11 more
Jul 19, 2021
Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis
Completed
- Genetic Obesity
- +2 more
- Setmelanotide
-
Birmingham, Alabama
- +57 more
Dec 22, 2022
Leptin Receptor Deficiency Obesity Trial in Worldwide (setmelanotide, Placebo)
Completed
- Leptin Receptor Deficiency Obesity
- setmelanotide
- Placebo
-
New York, New York
- +6 more
Jan 26, 2021
Pro-opiomelanocortin (POMC) Deficiency Obesity Trial in Worldwide (Setmelanotide, Placebo)
Completed
- Pro-opiomelanocortin (POMC) Deficiency Obesity
- Setmelanotide
- Placebo
-
Scottsdale, Arizona
- +6 more
Jan 26, 2021